CONTEXT: Chinese-American women have bone microarchitectural features that confer greater bone stiffness compared to white women, but the physiology underlying these findings has not been investigated. OBJECTIVE: The purpose of the study was to assess racial differences in serum sclerostin and bone turnover markers (BTMs), and to explore their associations with each other, volumetric bone mineral density (BMD), and bone microarchitecture in Chinese-American and white women. DESIGN AND SETTING: We conducted a cross-sectional study at a university hospital. PARTICIPANTS: We studied 138 women. RESULTS: Serum osteocalcin was 19-28% lower in pre- and postmenopausal Chinese-American vs white women, respectively (both P < .01). C-Terminal telopeptide of type I collagen (CTX) level was 18-22% lower in pre- and postmenopausal Chinese-American vs white women (both P < .05). Pre- vs postmenopausal differences in osteocalcin and CTX were greater in white vs Chinese-American women. Sclerostin levels were similar in both races, but BTMs were differentially associated with sclerostin by race and menopausal status. BTMs were not correlated with sclerostin in Chinese-Americans. CTX and bone-specific alkaline phosphatase were positively associated with sclerostin (r = 0.353, r = 0.458; both P < .05) in white premenopausal women. In contrast, in postmenopausal white women, the associations of sclerostin with amino-terminal propeptide of type I procollagen, isoform 5b of tartrate-resistant acid phosphatase, and CTX were negative (all P < .05). Adjusting for covariates, sclerostin was positively associated with areal BMD in both races. CONCLUSIONS: Lower BTMs in Chinese-American women and greater age-related differences in BTMs among white women provide a physiological framework to account for racial differences in BMD, microarchitecture, and fracture.
CONTEXT: Chinese-American women have bone microarchitectural features that confer greater bone stiffness compared to white women, but the physiology underlying these findings has not been investigated. OBJECTIVE: The purpose of the study was to assess racial differences in serum sclerostin and bone turnover markers (BTMs), and to explore their associations with each other, volumetric bone mineral density (BMD), and bone microarchitecture in Chinese-American and white women. DESIGN AND SETTING: We conducted a cross-sectional study at a university hospital. PARTICIPANTS: We studied 138 women. RESULTS: Serum osteocalcin was 19-28% lower in pre- and postmenopausal Chinese-American vs white women, respectively (both P < .01). C-Terminal telopeptide of type I collagen (CTX) level was 18-22% lower in pre- and postmenopausal Chinese-American vs white women (both P < .05). Pre- vs postmenopausal differences in osteocalcin and CTX were greater in white vs Chinese-American women. Sclerostin levels were similar in both races, but BTMs were differentially associated with sclerostin by race and menopausal status. BTMs were not correlated with sclerostin in Chinese-Americans. CTX and bone-specific alkaline phosphatase were positively associated with sclerostin (r = 0.353, r = 0.458; both P < .05) in white premenopausal women. In contrast, in postmenopausal white women, the associations of sclerostin with amino-terminal propeptide of type I procollagen, isoform 5b of tartrate-resistant acid phosphatase, and CTX were negative (all P < .05). Adjusting for covariates, sclerostin was positively associated with areal BMD in both races. CONCLUSIONS: Lower BTMs in Chinese-American women and greater age-related differences in BTMs among white women provide a physiological framework to account for racial differences in BMD, microarchitecture, and fracture.
Authors: Marcella D Walker; X Sherry Liu; Bin Zhou; Shivani Agarwal; George Liu; Donald J McMahon; John P Bilezikian; X Edward Guo Journal: J Bone Miner Res Date: 2013-06 Impact factor: 6.741
Authors: P Garnero; E Hausherr; M C Chapuy; C Marcelli; H Grandjean; C Muller; C Cormier; G Bréart; P J Meunier; P D Delmas Journal: J Bone Miner Res Date: 1996-10 Impact factor: 6.741
Authors: W Balemans; M Ebeling; N Patel; E Van Hul; P Olson; M Dioszegi; C Lacza; W Wuyts; J Van Den Ende; P Willems; A F Paes-Alves; S Hill; M Bueno; F J Ramos; P Tacconi; F G Dikkers; C Stratakis; K Lindpaintner; B Vickery; D Foernzler; W Van Hul Journal: Hum Mol Genet Date: 2001-03-01 Impact factor: 6.150
Authors: W Balemans; N Patel; M Ebeling; E Van Hul; W Wuyts; C Lacza; M Dioszegi; F G Dikkers; P Hildering; P J Willems; J B G M Verheij; K Lindpaintner; B Vickery; D Foernzler; W Van Hul Journal: J Med Genet Date: 2002-02 Impact factor: 6.318
Authors: Joel S Finkelstein; Mei-Ling T Lee; MaryFran Sowers; Bruce Ettinger; Robert M Neer; Jennifer L Kelsey; Jane A Cauley; Mei-Hua Huang; Gail A Greendale Journal: J Clin Endocrinol Metab Date: 2002-07 Impact factor: 5.958
Authors: Joel S Finkelstein; MaryFran Sowers; Gail A Greendale; Mei-Ling T Lee; Robert M Neer; Jane A Cauley; Bruce Ettinger Journal: J Clin Endocrinol Metab Date: 2002-07 Impact factor: 5.958
Authors: Olof Johnell; John A Kanis; Dennis M Black; Adam Balogh; Gyula Poor; Somnath Sarkar; Chunmei Zhou; Imre Pavo Journal: J Bone Miner Res Date: 2004-02-16 Impact factor: 6.741
Authors: Chrysoula G Liakou; George Mastorakos; Konstantinos Makris; Ioannis G Fatouros; Alexandra Avloniti; Helen Marketos; Julia D Antoniou; Antonios Galanos; Ismene Dontas; Demetrios Rizos; Symeon Tournis Journal: Endocrine Date: 2016-09-06 Impact factor: 3.633
Authors: C Swanson; S A Shea; P Wolfe; S Markwardt; S W Cain; M Munch; C A Czeisler; E S Orwoll; O M Buxton Journal: Osteoporos Int Date: 2017-07-26 Impact factor: 4.507
Authors: Elżbieta Skowrońska-Jóźwiak; Krzysztof C Lewandowski; Zbigniew Adamczewski; Kinga Krawczyk-Rusiecka; Andrzej Lewiński Journal: Int J Endocrinol Date: 2015-08-23 Impact factor: 3.257
Authors: Ryan D Ross; Anjali Sharma; Qiuhu Shi; Donald R Hoover; Kathleen M Weber; Phyllis C Tien; Audrey L French; Lena Al-Harthi; Michael T Yin Journal: Bone Rep Date: 2020-05-11